Cargando…

Cardiac MRI predictors for development of atrial fibrillation or flutter in patients with hypertrophic cardiomyopathy

Detalles Bibliográficos
Autores principales:	She, Helen Hoi Lam, Chan, Michael Pak Hei, Ma, Ka Fai Johnny
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4328480/ http://dx.doi.org/10.1186/1532-429X-17-S1-P281

Ejemplares similares

Electrocardiographic and Echocardiographic Predictors of Atrial Fibrillation in Patients With Hypertrophic Cardiomyopathy
por: Mandeş, Leonard, et al.
Publicado: (2022)

Anesthetic management of a patient with hypertrophic cardiomyopathy with atrial flutter posted for percutaneous nephrolithotomy
por: Nama, Rajnish K., et al.
Publicado: (2015)

A Rare Cause of Syncope: Apical Biventricular Hypertrophic Cardiomyopathy Complicated by Atrial Flutter
por: Cinar, Tufan, et al.
Publicado: (2020)

Predictors of the Atrial Fibrillation Following Catheter Ablation of Typical Atrial Flutter.
por: Haghjoo, Majid, et al.
Publicado: (2013)

Late gadolinium enhancement as an independent predictor of atrial fibrillation in hypertrophic cardiomyopathy (HCM)
por: O'Hanlon, Rory, et al.
Publicado: (2009)

Hypertrophic Cardiomyopathy and Atrial Fibrillation: A Review
por: Palyam, Vishnu, et al.
Publicado: (2022)

Pharmacological cardioversion for atrial fibrillation and flutter
por: Cordina, J, et al.
Publicado: (2006)

CMR findings in patients with hypertrophic cardiomyopathy and atrial fibrillation
por: Papavassiliu, Theano, et al.
Publicado: (2009)

Multimodality Imaging in Patients with Hypertrophic Cardiomyopathy and Atrial Fibrillation
por: Chung, Hyemoon, et al.
Publicado: (2023)

Hypertrophic cardiomyopathy masquerading as infiltrative restrictive cardiomyopathy and refractory congestive failure-resolution with catheter ablation of atrial flutter – A case report
por: Kalavakolanu, Sharada Sivaram
Publicado: (2015)

Atrial Fibrillation in Hypertrophic Cardiomyopathy: Is the Extent of Septal Hypertrophy Important?
por: Park, Kyoung-min, et al.
Publicado: (2016)

Left ventricular remodeling in hypertrophic cardiomyopathy patients with atrial fibrillation
por: Tian, Hongwei, et al.
Publicado: (2018)

Thinking Outside the Heart to Treat Atrial Fibrillation in Hypertrophic Cardiomyopathy
por: Rowin, Ethan J., et al.
Publicado: (2020)

State-of-the-Art Treatments for Atrial Fibrillation in Patients with Hypertrophic Cardiomyopathy
por: Penela, Diego, et al.
Publicado: (2021)

Magnetic resonance detection of advanced atrial cardiomyopathy increases the risk for atypical atrial flutter occurrence following atrial fibrillation ablation
por: Ferró, Elisenda, et al.
Publicado: (2023)

Dronedarone for the treatment of atrial fibrillation and atrial flutter: approval and efficacy
por: Wolbrette, Deborah, et al.
Publicado: (2010)

Substrate-based ablation of atypical atrial flutter in patients with atrial cardiomyopathy
por: Pott, Alexander, et al.
Publicado: (2022)

Ibutilide with magnesium for conversion of atrial fibrillation or flutter in rheumatic heart disease patients: Ibutilide with magnesium for chemical cardioversion of atrial fibrillation or flutter
por: Malviya, Amit, et al.
Publicado: (2020)

Utilization and Complications of Catheter Ablation for Atrial Fibrillation in Patients With Hypertrophic Cardiomyopathy
por: Rozen, Guy, et al.
Publicado: (2020)

Ablation of Atrial Fibrillation in Hypertrophic Cardiomyopathy: Semper Discere (Always Learning)
por: Estes, N. A. Mark, et al.
Publicado: (2021)

Clinical significance of new‐onset atrial fibrillation in patients with hypertrophic cardiomyopathy
por: Kubo, Toru, et al.
Publicado: (2021)

Surgical and transcatheter left atrial appendage closure in patients with atrial fibrillation and hypertrophic cardiomyopathy
por: Khawaja, Tasveer, et al.
Publicado: (2023)

Predictors of atrial flutter recurrence after atrial fibrillation ablation: the crucial role of structural and morphological left atrial remodeling
por: Guichard, J B, et al.
Publicado: (2023)

Impact of dronedarone in atrial fibrillation and flutter on stroke reduction
por: Christiansen, Christine Benn, et al.
Publicado: (2010)

Safety and Efficacy of Dronedarone in the Treatment of Atrial Fibrillation/Flutter
por: Naccarelli, Gerald V., et al.
Publicado: (2011)

387. Markers for Mortality in COVID-19 Patients with Atrial Fibrillation or Flutter
por: Chan, Kok Hoe, et al.
Publicado: (2020)

Is HATCH score a reliable predictor of atrial fibrillation after cavotricuspid isthmus ablation for typical atrial flutter?
por: García-Seara, Javier, et al.
Publicado: (2016)

Symptoms and quality of life in patients with coexistent atrial fibrillation and atrial flutter
por: Stempfel, Samuel, et al.
Publicado: (2020)

The Short QTc Is a Marker for the Development of Atrial Flutter and Atrial Fibrillation
por: Rabkin, Simon W., et al.
Publicado: (2020)

Epi-endocardial asynchrony during atrial flutter followed by atrial fibrillation
por: van Staveren, Lianne N., et al.
Publicado: (2021)

Patterns of Anticoagulation Use in Patients With Cancer With Atrial Fibrillation and/or Atrial Flutter
por: Fradley, Michael G., et al.
Publicado: (2020)

Anticoagulation in Cancer Patients With Atrial Fibrillation or Atrial Flutter: Are There Gaps in Care?
por: Russo, Andrea M.
Publicado: (2020)

Risk assessment of pre-excitation: Atrial fibrillation versus atrial flutter
por: Uniat, Jonathan, et al.
Publicado: (2022)

Right Ventricular and Right Atrial Involvement Can Predict Atrial Fibrillation in Patients with Hypertrophic Cardiomyopathy?
por: Doesch, Christina, et al.
Publicado: (2016)

Clinical impact of atrial fibrillation in a nationwide cohort of hypertrophic cardiomyopathy patients
por: Lee, Hyun-Jung, et al.
Publicado: (2020)

Impact of catheter ablation on atrial fibrillation burden and symptoms in patients with hypertrophic cardiomyopathy
por: Ahluwalia, N, et al.
Publicado: (2023)

Ehrlichiosis-Induced Atrial Flutter: An Unusual Cause of Atrial Flutter
por: Kunnumpurath, Anthony, et al.
Publicado: (2020)

Machine Learning Methods for Identifying Atrial Fibrillation Cases and Their Predictors in Patients With Hypertrophic Cardiomyopathy: The HCM-AF-Risk Model
por: Bhattacharya, Moumita, et al.
Publicado: (2021)

The Role of Dronedarone in the Treatment of Atrial Fibrillation/Flutter in the Aftermath of PALLAS
por: Naccarelli, Gerald V, et al.
Publicado: (2014)

Endurance sport practice as a risk factor for atrial fibrillation and atrial flutter
por: Mont, Lluís, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_oa34qrsfue53gt07cvo16fqm7u